Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 11—November 2004

Perspective

Trachoma Decline and Widespread Use of Antimicrobial Drugs

Jaya D. Chidambaram*, Mariko Bird*, Vivian Schiedler*, Alicia M. Fry†, Travis Porco‡, Ramesh C. Bhatta§, Hem Jha§, J.S.P. Chaudary§, Bruce Gaynor*, Elizabeth Yi*, John P. Whitcher*, Susie Osaki-Holm*, and Thomas M. Lietman*Comments to Author 
Author affiliations: *University of California, San Francisco, California, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ‡California Department of Health Services, Berkeley, California, USA; §Geta Eye Hospital, Geta, Nepal

Main Article

Figure 1

Antimicrobial drug use in Geta, Nepal. Antimicrobial drug sales in a 3-month period (mid-February to mid-May 2000) from all pharmacies in the Geta subdistrict, expressed as defined daily doses (DDDs) and as a percentage of the total DDDs sold (6). The shaded region represents antimicrobial drugs that are effective against Chylmydia trachomatis.

Figure 1. Antimicrobial drug use in Geta, Nepal. Antimicrobial drug sales in a 3-month period (mid-February to mid-May 2000) from all pharmacies in the Geta subdistrict, expressed as defined daily doses (DDDs) and as a percentage of the total DDDs sold (6). The shaded region represents antimicrobial drugs that are effective against Chylmydia trachomatis.

Main Article

TOP